14 January 2011

Buy Infosys Technologies Ltd: Target Rs 3,750

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Infosys reported USD revenue growth of 5.9%QoQ led by
volume growth of 3.1%QoQ. It was tad disappointing
because of lower volume growth (guidance for Q3 was 3.5-
4.5%QoQ, which was purely volume led) and hence lower
EPS, and also due to muted outlook for Q4. We expect a
strong revenue growth in FY12E, which is echoed by the
management’s broad outlook of 18-20%YoY USD revenue
growth for FY12 at this point of time.

Muted Q3FY11 as compared to Q2FY11 – We expected this
quarter to be slightly muted as compared to Q2FY11. Infosys
revenues grew 2.3%QoQ to Rs71,060mn (PINCe Rs71,377mn).
EBIT margins were flat at 30.2% despite rupee appreciation;
margins were supported by higher realizations and offshoring.
Pricing grew 1.6%QoQ. It raised its USD revenue guidance to
25-26%YoY growth (earlier 24-25%). EPS grew 2.5%QoQ to
Rs31.2 (PINCe Rs31.2) led by marginally higher other income.
BFSI and manufacturing lead the pack; muted growth in
US, ROW outperforms– BFSI dominated globally with
increased spending on IT and grew 8.3%QoQ. Manufacturing
and retail grew 9.9%QoQ and 6.7%QoQ respectively. US
witnessed muted growth of 4.2%QoQ after large ramp ups in
the last few quarters, India and ROW outperformed with
11%QoQ and 16.2%QoQ growth, respectively.
Persistent uptick in discretionary spend; high new client
wins- This quarter too witnessed an uptick in discretionary
spend led by application development, consulting & PI and
product engineering which grew 5.9%QoQ, 6.4%QoQ and
10.2%QoQ, respectively. 40 new clients were added in Q3FY11.
Outlook – Strong employee addition, large deal pipeline
and stable margins
Infosys is on track for its hiring guidance of 40,000(gross adds)
in FY11. Highest lateral addition of 5,212 was recorded in this
quarter. The company has given 26,000 campus offers for FY12.
Deal pipeline is strong with large transformational programs.
We expect EBIT margins to remain stable in the near term.
We have introduced FY13E financials. We maintain our ‘BUY’
recommendation with a target price of Rs3,750 based on
21xFY13E earnings.

No comments:

Post a Comment